Table 5.
Plasma Vardenafil Pharmacokinetic Parameters After Administration of Single Doses of Vardenafil as 0.6 mg Inhaled RT234 and 20 mg Oral Levitra Tablets to Healthy Subjects
Treatment | Mean (CV%) plasma vardenafil pharmacokinetic parameter values |
|||
---|---|---|---|---|
tmaxa (h) | Cmax (ng/mL) | AUC(0–last) (h · ng/mL) | AUC(0–inf) (h · ng/mL) | |
0.6 mg RT234 (N = 5) | 0.03 | 3.178 (65) | 4.052 (18) | 4.348 (18) |
20 mg oral Levitra (N = 5) | 0.75 | 21.16 (30) | 53.15 (29) | 54.36 (29) |
20 mg oral Levitra/0.6 mg RT234 | 25 | 6.7 | 13.1 | 12.5 |
Mean (CV%) plasma vardenafil bioavailability parameter values after administration of 2.4 mg RT234 | ||||
Cmax (ng/mL) | AUC(0–last) (h · ng/mL) | AUC(0–inf) (h · ng/mL) | ||
2.4 mg RT234 (N = 6) | 8.467 (40) | 18.2 (15) | 18.67 (14) | |
20 mg oral Levitra/2.4 mg RT234 | 2.5 | 2.9 | 2.9 |
Median tmax displayed.